This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Maximizing The Effectiveness Of Market Research Groups Through Outsourcing And Automation

CHAPEL HILL, N.C., Jan. 17, 2013 /PRNewswire/ -- Market research executives in the healthcare sector need to continually evaluate the need for outsourced personnel. In the dynamic biopharmaceutical marketplace, cost-saving tactics such as outsourcing and automation can enhance efficiency and maintain performance across different functions, including market research.

A recent study by research and consulting firm Best Practices, LLC found that while the need for externally contracted labor varies widely among biopharma companies, outsourcing personnel for primary research is the most common need among market research leaders. A majority of companies in the study also have been successful in implementing the use of automation into their market research operation.

"Market Research Efficiency Benchmark: Using External Personnel and Automation to Maximize Effectiveness" is a new report that pinpoints innovative approaches and strategies for increasing efficiency through the use of automation and outsourced labor in market research groups.

Issues addressed in the study include:
  • Maximizing efficiency and maintaining a lean internal headcount in the face of increased workload
  • Automate market research processes for efficient report generation and better knowledge management
  • Methods used to implement and manage automated systems

The research also examines best practices in relation to the type and quantity of outsourcing used by market research leaders at leading biopharmaceutical companies.

More than 50% of all respondents predicted no change or even reductions in internal staffing levels in the next two years. Leaders burdened with headcount constraints can gain critical insights from this study that will help them maintain an effective, efficient market research group through the use of outsourced labor and automation.

This benchmarking research project drew participation from 22 market research executives from 19 different pharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with seven participating industry veterans to gather additional insights.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,630.27 +189.68 1.09%
S&P 500 2,093.25 +25.61 1.24%
NASDAQ 5,089.2060 +49.43 0.98%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs